Evidence map›Paper›PMID 39975275›Full record

ArticlebioRxiv : the preprint server for biology2025

Systematic pre-annotation explains the "dark matter" in LC-MS metabolomics.

Yuanye Chi, Joshua M Mitchell, Shujian Zheng, Shuzhao Li

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yuanye ChiThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA.
Joshua M MitchellThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA.
Shujian ZhengThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA.
Shuzhao LiThe Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA.

Funding

TBDR01AI149746 · NIAID · JACKSON LABORATORY · PI LI, SHUZHAO · 2020 to 2024
$2.6M
NIAID NIH HHS R01 AI149746
6 · The paper itself

Abstract

The majority of features in global metabolomics from high-resolution mass spectrometry are typically not identified, referred as the "dark matter". Are these features real compounds or junk? Understanding this problem is critical to the annotation and interpretation of metabolomics data and future development of the field. Recent debates also brought attention to in-source fragments, which appear to be prevalent in spectral databases. We report here a systematic analysis of 61 representative public datasets from LC-MS metabolomics, the most common data type in biomedical studies. The results indicate that in-source fragments contribute to less than 10% of features in LC-MS metabolomics. Khipu-based pre-annotation shows that majority of abundant features have identifiable ion patterns. This suggests that the "dark matter" in LC-MS metabolomics is explainable in an abundance dependent manner; most features are from real compounds; the number of compounds is much smaller than that of features; most compounds are yet to be identified.

Identifiers

PMID39975275
PMCPMC11838597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.